Connectyx Technologies
Business Services · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
49 SW Flagler Ave Ste 302, Stuart, Flori...Phone Number
(772) 221-8536Website
www.connectyx.comRevenue
$6.5 MillionIndustry
About Connectyx Technologies
Connectyx Technologies Org Chart
Is Connectyx Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Connectyx Technologies has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Connectyx Technologies launches new products
Congratulate Masked Content for being promoted to Masked Content at Connectyx Technologies
Click to see if Connectyx Technologies had a recent Job posting/layoffs
Check out if Connectyx Technologies is spiking on competitors!
Check if Connectyx Technologies has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Connectyx Technologies recently announced quarterly report
Connectyx Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Connectyx Technologies as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Connectyx Technologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Connectyx Technologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Connectyx Technologies.
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Connectyx Technologies
Curative Biotechnology focuses on identifying, acquiring, and developing disease-modifying therapeutic drug candidates, particularly for rare disease indications. The company aims to build a pipeline of first-in-class drugs with accelerated development pathways to address unmet medical needs. Their current development assets target degenerative eye... Read More